• Je něco špatně v tomto záznamu ?

Brain abscess and pyocephalus: our experience with treatment

Z. Večeřa, O. Krejčí, T. Krejčí, J. Krajča, M. Kanta, R. Lipina,

. 2019 ; 53 (2) : 162-168. [pub] 20190425

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19027645

INTRODUCTION: Pyocephalus always presents serious complications in the treatment of brain abscesses, and is associated with high rates of mortality and morbidity. This study aimed to comprehensively evaluate this understandably feared complication from a purely medical perspective by using an evidence-based approach and drawing comparisons from the available literature, which mostly comprises case reports. METHODS: This was a prospective monocentric study of all patients treated for brain abscesses at the Neurosurgery Clinic of the University Hospital Ostrava between 2012 and 2017. The cohort was divided into two groups for statistical comparison; one group comprised those in which pyocephalus occurred before or during treatment, while the other group comprised patients without this complication. Particular consideration was given to the effect of pyocephalus on morbidity and mortality rates and C-reactive protein levels, as well as to the identification of risk factors, and to its possible therapeutic influence. Patients were followed up for six months. RESULTS: A total of 43 patients were treated for a brain abscess. An unequivocal diagnosis of pyocephalus was established via CT and MRI brain scans in five cases (11.6%). In the cohort as a whole, mortality and morbidity rates were 23.3% and 48.8% respectively. Among patients with pyocephalus the incidence of mortality and morbidity was 40% and 66.6% respectively. The presence of pyocephalus is not a significant predictor of either morbidity (p 0.575) or mortality (p 0.664). In patients with pyocephalus, we determined elevated CRP levels on the day of surgery (p 0.038). The occurrence of epileptic seizures in the acute phase of the disease is associated with a poor outcome (p 0.039). CONCLUSIONS: Pyocephalus will continue to be a serious complication in the treatment of brain abscesses, although we were unable to determine its utility as a prognostic factor. Patients with this complication have elevated CRP levels on the day of operation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027645
003      
CZ-PrNML
005      
20190823103947.0
007      
ta
008      
190813s2019 pl f 000 0|eng||
009      
AR
024    7_
$a 10.5603/PJNNS.a2019.0017 $2 doi
035    __
$a (PubMed)31020989
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Večeřa, Zdeněk $u University hospital Ostrava, Czech Republic. Faculty of Medicine, Ostrava University.
245    10
$a Brain abscess and pyocephalus: our experience with treatment / $c Z. Večeřa, O. Krejčí, T. Krejčí, J. Krajča, M. Kanta, R. Lipina,
520    9_
$a INTRODUCTION: Pyocephalus always presents serious complications in the treatment of brain abscesses, and is associated with high rates of mortality and morbidity. This study aimed to comprehensively evaluate this understandably feared complication from a purely medical perspective by using an evidence-based approach and drawing comparisons from the available literature, which mostly comprises case reports. METHODS: This was a prospective monocentric study of all patients treated for brain abscesses at the Neurosurgery Clinic of the University Hospital Ostrava between 2012 and 2017. The cohort was divided into two groups for statistical comparison; one group comprised those in which pyocephalus occurred before or during treatment, while the other group comprised patients without this complication. Particular consideration was given to the effect of pyocephalus on morbidity and mortality rates and C-reactive protein levels, as well as to the identification of risk factors, and to its possible therapeutic influence. Patients were followed up for six months. RESULTS: A total of 43 patients were treated for a brain abscess. An unequivocal diagnosis of pyocephalus was established via CT and MRI brain scans in five cases (11.6%). In the cohort as a whole, mortality and morbidity rates were 23.3% and 48.8% respectively. Among patients with pyocephalus the incidence of mortality and morbidity was 40% and 66.6% respectively. The presence of pyocephalus is not a significant predictor of either morbidity (p 0.575) or mortality (p 0.664). In patients with pyocephalus, we determined elevated CRP levels on the day of surgery (p 0.038). The occurrence of epileptic seizures in the acute phase of the disease is associated with a poor outcome (p 0.039). CONCLUSIONS: Pyocephalus will continue to be a serious complication in the treatment of brain abscesses, although we were unable to determine its utility as a prognostic factor. Patients with this complication have elevated CRP levels on the day of operation.
650    12
$a absces mozku $7 D001922
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a prospektivní studie $7 D011446
650    _2
$a rizikové faktory $7 D012307
650    _2
$a záchvaty $7 D012640
655    _2
$a časopisecké články $7 D016428
700    1_
$a Krejčí, Ondřej $u University hospital Ostrava, Czech Republic. Faculty of Medicine, Ostrava University.
700    1_
$a Krejčí, Tomáš $u University hospital Ostrava, Czech Republic. Faculty of Medicine, Ostrava University.
700    1_
$a Krajča, Jan $u University hospital Ostrava, Czech Republic. Radiodiagnostics Department, University Hospital Ostrava.
700    1_
$a Kanta, Martin $u Department of Neurosurgery, University Hospital Hradec Králové, Czech Republic. Charles University, Faculty of Medicine in Hradec Králové.
700    1_
$a Lipina, Radim $u University hospital Ostrava, Czech Republic. neurosurgery@fno.cz. Faculty of Medicine, Ostrava University. neurosurgery@fno.cz.
773    0_
$w MED00003489 $t Neurologia i neurochirurgia polska $x 0028-3843 $g Roč. 53, č. 2 (2019), s. 162-168
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31020989 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190823104201 $b ABA008
999    __
$a ok $b bmc $g 1432794 $s 1066105
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 53 $c 2 $d 162-168 $e 20190425 $i 0028-3843 $m Neurologia i Neurochirurgia Polska $n Neurol Neurochir Pol $x MED00003489
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...